Cannabis use has increased significantly in the US. This session will focus on the forces driving this rise in use, risk factors for the development of dependence, and outline the science related to cannabinoids. Risks, benefits, harms and dependence will be reviewed. Consequences of use, special risk categories and specific challenges related to cannabis use will be discussed. Approaches to screening and treatment of dependence will be outlined.
Upon completion of this webinar, attendees will be able to:
Understand that cannabis is not harmless
Appreciate the forces leading to increased use
Outline the approaches to screening and treatment
Mark Friedlander, M.D., M.B.A
Chief Medical Officer,
Behavioral Health at UHS
Dr. Mark Friedlander is the UHS Chief Medical Officer in the Behavioral Health Division. A board-certified psychiatrist, Dr. Friedlander’s responsibilities include medical strategy, thought leadership, oversight of medical staff across the network, and utilization management. Dr. Friedlander provides clinical leadership through coordinating the sharing of best practices to improve processes of care and reduce errors; provides a mechanism to harness the talent of the physician workforce, increase their engagement, and provide a sense of purpose beyond daily patient care. Dr. Friedlander directs subgroups addressing specific topics such as suicide prevention, detox, the EMR, recruitment, and academic partnerships and training.
This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840. NACCME is responsible for all aspects of the programing.
This training could be applied to multiple areas of the Alaska Qualified Addictions Professional (QAP) certification. Contact the Alaska Commission for Behavioral Health Certification (Ask for Dabney Van Liere, Executive Director) at 907-332-4333 or email firstname.lastname@example.org for specific information.